Akebia Therapeutics (AKBA): Raising PT On Key Contract - HC Wainwright

May 16, 2017 7:26 AM

H.C. Wainwright analyst, Ed Arce, reiterated his Neutral rating on shares of Akebia Therapeutics (NASDAQ: AKBA) and raised his price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found